Skip to content
You are not authorized to view this resource.
You need to login.
Please update your
to view content.
Sagent Pharmaceuticals Announces Agreement to Acquire Remaining 50% Interest in Chinese Manufacturing Joint Venture
Sagent Pharmaceuticals Reports First Quarter 2013 Financial Results
Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial Results
SAGENT PHARMACEUTICALS, SAGENT, INJECTABLES EXCELLENCE and DISCOVER INJECTABLES EXCELLENCE
are trademarks of Sagent Pharmaceuticals, Inc.©2007-2013 Sagent Pharmaceuticals, Inc.